Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMOORE, Nicholas
dc.contributor.authorFAUCHIER, L.
dc.contributor.authorSACHER, F.
dc.contributor.authorDUREAU-POURNIN, C.
dc.contributor.authorBERNARD, M. A.
dc.contributor.authorLASSALLE, R.
dc.contributor.authorDALLONGEVILLE, J.
dc.contributor.authorDROZ-PERROTEAU, C.
dc.contributor.authorBLIN, Patrick
dc.date.accessioned2020-12-08T13:24:27Z
dc.date.available2020-12-08T13:24:27Z
dc.date.issued2018-08
dc.identifier.issn0195-668Xen_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/21359
dc.language.isoENen_US
dc.subject.enPharmacoEpi-Drugs
dc.subject.enCIC1401
dc.title.enBenefit-risk of rivaroxaban 20 or 15mg compared to vitamin-K antagonists in patients with non-valvular atrial fibrillation: a cohort study in the French nationwide claims database
dc.title.alternativeEuropean Heart Journalen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1093/eurheartj/ehy563.P4820en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
bordeaux.journalEuropean Heart Journalen_US
bordeaux.page1014-1014en_US
bordeaux.volume39en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamPharmacoEpi-Drugsen_US
bordeaux.teamCIC1401en_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03046529
hal.version1
hal.date.transferred2020-12-08T13:24:32Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=European%20Heart%20Journal&rft.date=2018-08&rft.volume=39&rft.spage=1014-1014&rft.epage=1014-1014&rft.eissn=0195-668X&rft.issn=0195-668X&rft.au=MOORE,%20Nicholas&FAUCHIER,%20L.&SACHER,%20F.&DUREAU-POURNIN,%20C.&BERNARD,%20M.%20A.&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée